FDA grants fast track status to volixibat
The Food and Drug Administration has granted fast track status to volixibat, an investigational treatment manufactured by Shire.
“The FDA’s fast track is a process designed to facilitate the...
Source: Family Practice News - Category: Primary Care Source Type: news